Esperion Therapeutics Valuation
| ESPR Stock | USD 1.95 0.08 4.28% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Esperion Therapeutics shows a prevailing Real Value of $4.18 per share. The current price of the firm is $1.95. Our model computes the value of Esperion Therapeutics from reviewing the firm fundamentals such as Shares Outstanding of 189.4 M, profit margin of (1.80) %, and Current Valuation of 812.15 M as well as analyzing its technical indicators and probability of bankruptcy. In general, most investors advise buying undervalued instruments and selling overvalued instruments since, at some point, asset prices and their ongoing real values will submerge. Key fundamental drivers impacting Esperion Therapeutics' valuation include:
Price Book 74.8863 | Enterprise Value 812.1 M | Enterprise Value Ebitda (3.86) | Price Sales 3.4041 | Forward PE 1.028 |
Undervalued
Today
Please note that Esperion Therapeutics' price fluctuation is risky at this time. Calculation of the real value of Esperion Therapeutics is based on 3 months time horizon. Increasing Esperion Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Esperion Therapeutics is useful when determining the fair value of the Esperion stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Esperion Therapeutics. Since Esperion Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Esperion Stock. However, Esperion Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.95 | Real 4.18 | Target 11.13 | Hype 1.86 |
The real value of Esperion Stock, also known as its intrinsic value, is the underlying worth of Esperion Therapeutics Company, which is reflected in its stock price. It is based on Esperion Therapeutics' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Esperion Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Esperion Therapeutics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Esperion Therapeutics helps investors to forecast how Esperion stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Esperion Therapeutics more accurately as focusing exclusively on Esperion Therapeutics' fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Esperion Therapeutics' intrinsic value based on its ongoing forecasts of Esperion Therapeutics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Esperion Therapeutics' closest peers. When choosing an evaluation method for Esperion Therapeutics, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Esperion Therapeutics Investments |
|
Esperion Valuation Trend
Knowing Esperion Therapeutics' actual value is paramount for traders to make sound investment determinations. Esperion Therapeutics' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Esperion Therapeutics' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Esperion Therapeutics' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Esperion Market Cap
Esperion Therapeutics is rated below average in market capitalization category among related companies. Market capitalization of Health Care industry is currently estimated at about 58.4 Billion. Esperion Therapeutics maintains roughly 361.76 Million in market capitalization contributing less than 1% to equities under Health Care industry.Esperion Therapeutics Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Esperion Therapeutics's current stock value. Our valuation model uses many indicators to compare Esperion Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Esperion Therapeutics competition to find correlations between indicators driving Esperion Therapeutics's intrinsic value. More Info.Esperion Therapeutics is rated below average in price to earning category among related companies. It is one of the top stocks in price to book category among related companies . As of 04/19/2024, Price To Book Ratio is likely to grow to -0.64. Comparative valuation analysis is a catch-all model that can be used if you cannot value Esperion Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Esperion Therapeutics' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Esperion Therapeutics' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Esperion Therapeutics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Esperion Therapeutics and how it compares across the competition.
About Esperion Therapeutics Valuation
The stock valuation mechanism determines the current worth of Esperion Therapeutics on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Esperion Therapeutics. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Esperion Therapeutics based exclusively on its fundamental and basic technical indicators. By analyzing Esperion Therapeutics's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Esperion Therapeutics's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Esperion Therapeutics. We calculate exposure to Esperion Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Esperion Therapeutics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 72.9 M | 69.3 M | |
| Pretax Profit Margin | (1.80) | (1.89) | |
| Operating Profit Margin | (1.34) | (1.40) | |
| Net Loss | (1.80) | (1.89) | |
| Gross Profit Margin | 0.63 | 0.46 |
8 Steps to conduct Esperion Therapeutics' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Esperion Therapeutics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Esperion Therapeutics' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Esperion Therapeutics' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Esperion Therapeutics' revenue streams: Identify Esperion Therapeutics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Esperion Therapeutics' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Esperion Therapeutics' growth potential: Evaluate Esperion Therapeutics' management, business model, and growth potential.
- Determine Esperion Therapeutics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Esperion Therapeutics' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Esperion Therapeutics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Esperion Therapeutics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 103.1 M | |
| Forward Price Earnings | 1.028 |
Esperion Therapeutics Current Valuation Indicators
Valuation refers to the process of determining the present value of Esperion Therapeutics and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Esperion we look at many different elements of the entity such as Esperion's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Esperion Therapeutics' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Esperion Therapeutics' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Esperion Therapeutics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Esperion Therapeutics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Esperion Therapeutics' worth.When determining whether Esperion Therapeutics is a strong investment it is important to analyze Esperion Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Esperion Therapeutics' future performance. For an informed investment choice regarding Esperion Stock, refer to the following important reports: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Esperion Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. To learn how to invest in Esperion Stock, please use our How to Invest in Esperion Therapeutics guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Complementary Tools for Esperion Stock analysis
When running Esperion Therapeutics' price analysis, check to measure Esperion Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Esperion Therapeutics is operating at the current time. Most of Esperion Therapeutics' value examination focuses on studying past and present price action to predict the probability of Esperion Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Esperion Therapeutics' price. Additionally, you may evaluate how the addition of Esperion Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |
Is Esperion Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Esperion Therapeutics. If investors know Esperion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Esperion Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.03) | Revenue Per Share 1.128 | Quarterly Revenue Growth 0.714 | Return On Assets (0.43) | Return On Equity (2.61) |
The market value of Esperion Therapeutics is measured differently than its book value, which is the value of Esperion that is recorded on the company's balance sheet. Investors also form their own opinion of Esperion Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Esperion Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Esperion Therapeutics' market value can be influenced by many factors that don't directly affect Esperion Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Esperion Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Esperion Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Esperion Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.